Related references
Note: Only part of the references are listed.Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants
Oana Ciofu et al.
MICROBIOLOGY-SGM (2010)
Nutrient Availability as a Mechanism for Selection of Antibiotic Tolerant Pseudomonas aeruginosa within the CF Airway
Lucas R. Hoffman et al.
PLOS PATHOGENS (2010)
Antibiotic Resistance in Pseudomonas aeruginosa Strains with Increased Mutation Frequency Due to Inactivation of the DNA Oxidative Repair System
L. F. Mandsberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression
Lucas R. Hoffman et al.
JOURNAL OF CYSTIC FIBROSIS (2009)
Simple Sequence Repeats and Mucoid Conversion: Biased mucA Mutagenesis in Mismatch Repair-Deficient Pseudomonas aeruginosa
Alejandro J. Moyano et al.
PLOS ONE (2009)
Effect of Mutator P. aeruginosa on Antibiotic Resistance Acquisition and Respiratory Function in Cystic Fibrosis
Agnes Ferroni et al.
PEDIATRIC PULMONOLOGY (2009)
Genetic Adaptation of Pseudomonas aeruginosa to the Airways of Cystic Fibrosis Patients Is Catalyzed by Hypermutation
A. Mena et al.
JOURNAL OF BACTERIOLOGY (2008)
Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa
David J. Waine et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants
Oana Ciofu et al.
MICROBIOLOGY-SGM (2008)
Resistance mechanisms of multiresistant pseudomonas aeruginosa strains from Germany and correlation with Hypermutationdel
B. Henrichfreise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents
V. Plasencia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis
Dervla T. Kenna et al.
MICROBIOLOGY-SGM (2007)
Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis
Sara Montanari et al.
MICROBIOLOGY-SGM (2007)
MutS deficiency and activity of the error-prone DNA polymerase IV are crucial for determining mucA as the main target for mucoid conversion in Pseudomonas aeruginosa
Alejandro J. Moyano et al.
MOLECULAR MICROBIOLOGY (2007)
Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain
Adela M. Lujan et al.
MICROBIOLOGY-SGM (2007)
Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients
David A. D'Argenio et al.
MOLECULAR MICROBIOLOGY (2007)
Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis
Michael Hogardt et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Role of Pseudomonas aeruginosa dinB-encoded DNA polymerase IV in mutagenesis
Laurie H. Sanders et al.
JOURNAL OF BACTERIOLOGY (2006)
Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolates
Michael Hogardt et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Eric E. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells:: Application for DNA fragment transfer between chromosomes and plasmid transformation
KH Choi et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2006)
Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections
MD Maciá et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pseudomonas aeruginosa MutL protein functions in Escherichia coli
DK Jacquelín et al.
BIOCHEMICAL JOURNAL (2005)
Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation
O Ciofu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients
O Gutiérrez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion
MD Maciá et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants:: Implications for susceptibility testing and treatment of chronic infections
A Oliver et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis
C Vogne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa
AM Smania et al.
MICROBIOLOGY-SGM (2004)
Comprehensive transposon mutant library of Pseudomonas aeruginosa
MA Jacobs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Pathophysiology and management of pulmonary infections in cystic fibrosis
RL Gibson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates
ML Sobel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome
L Garibyan et al.
DNA REPAIR (2003)
Vanadate inhibits the ATPase activity and DNA binding capability of bacterial MutS.: A structural model for the vanadate-MutS interaction at the Walker A motif
RJ Pezza et al.
NUCLEIC ACIDS RESEARCH (2002)
Lung infections associated with cystic fibrosis
JB Lyczak et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants
A Oliver et al.
MOLECULAR MICROBIOLOGY (2002)
Fidelity of replication of repetitive DNA in mutS and repair proficient Escherichia coli
DD Levy et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA
G Obmolova et al.
NATURE (2000)
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
A Oliver et al.
SCIENCE (2000)
Share Paper
